ARPA-H plans to cut clinical trials from 10+ years to under 4 with AI
Afinetheorem · x · 2026-10-02
ARPA-H outlined four plans to compress clinical trial timelines from 10+ years to under 4:
- Phaseless trials: adaptive designs replacing the phase 1→2→3 pipeline to kill failing drugs and advance good ones faster.
- Digital twins: simulating trial outcomes upfront to reduce reliance on large control groups.
- AI agents for trial operations.
- Converting ordinary hospitals into reusable trial sites, with AI flagging eligible trials to doctors and patients.
The poster adds that back-of-envelope math and the COVID experience both show speeding up and cheapening trials is an enormously valuable bottleneck to fix for useful innovation.
Related event: ARPA-H's SURPASS Aims to Cut Clinical Trials from 10 Years to 4(2 posts)→
More from AGI Musings
- DeepMind alignment researcher: frontier labs don't know how to instill values in AI — teropa · 2026-11-16
- AI Futures Project moves superhuman AI researcher forecast up to late 2027 — connoraxiotes · 2026-11-16
- Podcast: Arvind Narayanan on why AI may be a normal technology, not superintelligence — dioscuri · 2026-11-16
- After Teaching 500-1000 People the Terminal, He Says LLM Skeptics Who Don't Build Should Be Doubted — StewartalsopIII · 2026-11-16
- When teams share one AI model, group judgment quietly converges and erodes — DrKavner · 2026-11-16
- Uber earnings: AI agents booked just 4 of ~320M rides in Halloween week — thealexbanks · 2026-11-16